New research into allergic diseases is ongoing, especially the development and application of new biological agents. A researcher at the American College of Allergy, Asthma and Immunology (ACAAI), mentioned that traditional asthma treatments are ineffective for some people whose asthma cannot be controlled. Biologics are at the forefront of treatment because of their potential to personalize therapy to treat the cells that cause allergic inflammation and make breathing difficult for some people. To date, many biologics targeting Th2/1/17 inflammatory biomarkers are available, many of which are already in clinical use.
Learn more: Biologics for the Treatment of Allergic Diseases
